Genetic architecture of human thinness compared to severe obesity
Mounjaro Zepbound and Mounjaro both contain tirzepatide, but they are FDA-approved for different uses
Although it is not part of the diagnostic criteria, obesity is a common finding in women with PCOS, with a prevalence that ranges between 50 and 80% [4]
GLP-1 agonists, which primarily target extrahepatic mechanisms to ameliorate metabolic disorders, when used in conjunction with resmetirom, focusing on intrahepatic mechanisms, offer a complementary approach in the management of MASH and liver fibrosis
The 2010 RCT of 42 hirsute PCOS women showed measurable testosterone reduction and subjective hirsutism improvement on twice-daily spearmint tea (Grant 2010), and the earlier clinical trial established the anti-androgenic mechanism (Akdoan et al
As more people turn to GLP-1 telehealth services , it's essential to understand how this model is reshaping the future of prescription access and long-term health outcomes